{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T21:54:54Z","timestamp":1792446894802,"version":"4.5.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T00:00:00Z","timestamp":1770681600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001321","name":"National Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Korea Ministry of Science and ICT","doi-asserted-by":"publisher","award":["RS-2024-00440371"],"award-info":[{"award-number":["RS-2024-00440371"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Korea Ministry of Science and ICT","doi-asserted-by":"publisher","award":["RS-2024-00469788"],"award-info":[{"award-number":["RS-2024-00469788"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.jad.2026.121259","type":"journal-article","created":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T07:50:26Z","timestamp":1770709826000},"page":"121259","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Multimodal machine learning models for predicting remission in major depressive disorder using clinical data, blood biomarkers, and DNA methylation"],"prefix":"10.1016","volume":"402","author":[{"given":"Soonho","family":"Ha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee-Ju","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taeyeong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KyungMin","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-min","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hwamin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2026.121259_bb0005","series-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"1994"},{"issue":"4","key":"10.1016\/j.jad.2026.121259_bb0010","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1177\/0269881107088441","article-title":"Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 2000 British Association for Psychopharmacology guidelines","volume":"22","author":"Anderson","year":"2008","journal-title":"J. Psychopharmacol."},{"issue":"9","key":"10.1016\/j.jad.2026.121259_bb0015","doi-asserted-by":"crossref","first-page":"5112","DOI":"10.1038\/s41380-020-0808-3","article-title":"Epigenetic prediction of major depressive disorder","volume":"26","author":"Barbu","year":"2021","journal-title":"Mol. Psychiatry"},{"issue":"2","key":"10.1016\/j.jad.2026.121259_bb0020","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1080\/15622970701227829","article-title":"World Federation of Societies of biological psychiatry (WFSBP) guidelines for biological treatment of Unipolar Depressive Disorders in primary care","volume":"8","author":"Bauer","year":"2007","journal-title":"World J. Biol. Psychiatry"},{"issue":"5","key":"10.1016\/j.jad.2026.121259_bb0025","doi-asserted-by":"crossref","first-page":"334","DOI":"10.3109\/15622975.2013.804195","article-title":"World Federation of Societies of biological psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders, part J.-M. Kim, et al. 1: update 2013 on the acute and continuation treatment of unipolar depressive disorders","volume":"14","author":"Bauer","year":"2013","journal-title":"The world journal of biological psychiatry: the official journal of the world Federation of Societies of biological psychiatry"},{"key":"10.1016\/j.jad.2026.121259_bb0030","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.pharmthera.2014.11.016","article-title":"Glycogen synthase kinase-3 (GSK3): regulation, actions, and diseases","volume":"148","author":"Beurel","year":"2015","journal-title":"Pharmacol. Ther."},{"issue":"2","key":"10.1016\/j.jad.2026.121259_bb0035","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/wps.20882","article-title":"The promise of machine learning in predicting treatment outcomes in psychiatry","volume":"20","author":"Chekroud","year":"2021","journal-title":"World Psychiatry"},{"key":"10.1016\/j.jad.2026.121259_bb0040","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/s41398-021-01286-x","article-title":"Magnetic resonance imaging for individual prediction of treatment response in major depressive disorder: a systematic review and meta-analysis","volume":"11","author":"Cohen","year":"2021","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.jad.2026.121259_bb0045","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.3389\/fimmu.2020.01577","article-title":"Methylation vs. protein inflammatory biomarkers and their associations with cardiovascular function","volume":"11","author":"Cronj\u00e9","year":"2020","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.jad.2026.121259_bb0050","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-55356-x","article-title":"Insights from a methylome-wide association study of antidepressant exposure","volume":"16","author":"Davyson","year":"2025","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.jad.2026.121259_bb0055","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1080\/15592294.2016.1178418","article-title":"DNA methylation of loci within ABCG1 and PHOSPHO1 in blood DNA is associated with future type 2 diabetes risk","volume":"11","author":"Dayeh","year":"2016","journal-title":"Epigenetics"},{"key":"10.1016\/j.jad.2026.121259_bb0060","article-title":"Efficacy and acceptability of anti-inflammatory agents in major depressive disorder: a systematic review and meta-analysis","volume":"15","author":"Du","year":"2024","journal-title":"Front. Psychol."},{"key":"10.1016\/j.jad.2026.121259_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.jad.2025.119545","article-title":"Inflammatory biomarkers as predictors for unlocking antidepressant efficacy: assessing predictive value and risk stratification in major depressive disorder in a prospective longitudinal study","volume":"387","author":"Elbakary","year":"2025","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2026.121259_bb0070","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/s41586-021-03341-5","article-title":"The AIM2 inflammasome exacerbates atherosclerosis in clonal haematopoiesis","volume":"592","author":"Fidler","year":"2021","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.jad.2026.121259_bb0075","doi-asserted-by":"crossref","first-page":"36","DOI":"10.64719\/pb.4425","article-title":"Inflammatory biomarker and response to antidepressant in major depressive disorder: a systematic review and meta-analysis","volume":"52","author":"Gasparini","year":"2022","journal-title":"Psychopharmacol. Bull."},{"issue":"6","key":"10.1016\/j.jad.2026.121259_bb0080","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s40273-021-01019-4","article-title":"The economic burden of adults with major depressive disorder in the United States (2010 and 2018)","volume":"39","author":"Greenberg","year":"2021","journal-title":"Pharmacoeconomics"},{"issue":"1","key":"10.1016\/j.jad.2026.121259_bb0085","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"4","key":"10.1016\/j.jad.2026.121259_bb0090","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/da.23247","article-title":"Methylation of the AIM2 gene: an epigenetic mediator of PTSD-related inflammation and neuropathology plasma biomarkers","volume":"39","author":"Hawn","year":"2022","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.jad.2026.121259_bb0095","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1001\/jamapsychiatry.2021.4313","article-title":"Combining antidepressants vs antidepressant monotherapy for treatment of patients with acute depression: a systematic review and meta-analysis","volume":"79","author":"Henssler","year":"2022","journal-title":"JAMA Psychiatry"},{"issue":"5","key":"10.1016\/j.jad.2026.121259_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.xgen.2024.100544","article-title":"Blood-based epigenome-wide analyses of chronic low-grade inflammation across diverse population cohorts","volume":"4","author":"Hillary","year":"2024","journal-title":"Cell Genomics"},{"issue":"3\u20134","key":"10.1016\/j.jad.2026.121259_bb0105","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1093\/ilar.53.3-4.289","article-title":"Environmental epigenetics and its implication on disease risk and health outcomes","volume":"53","author":"Ho","year":"2012","journal-title":"ILAR J."},{"key":"10.1016\/j.jad.2026.121259_bb0110","doi-asserted-by":"crossref","DOI":"10.1186\/s12916-017-0791-y","article-title":"A randomised controlled trial of dietary improvement for adults with major depression (the \u201cSMILES\u201d trial)","volume":"15","author":"Jacka","year":"2017","journal-title":"BMC Med."},{"issue":"5","key":"10.1016\/j.jad.2026.121259_bb0115","doi-asserted-by":"crossref","first-page":"538","DOI":"10.30773\/pi.2017.10.2","article-title":"The MAKE biomarker discovery for enhancing anTidepressant treatment effect and response (MAKE BETTER) study: design and methodology","volume":"15","author":"Kang","year":"2018","journal-title":"Psychiatry Investig."},{"key":"10.1016\/j.jad.2026.121259_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2020.110176","article-title":"Genetic markers for depressive disorders with earlier age at onset","volume":"108","author":"Kang","year":"2021","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.jad.2026.121259_bb0125","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/mp.2016.167","article-title":"Antidepressant activity of anti-cytokine treatment: a systematic review and meta-analysis of clinical trials of chronic inflammatory conditions","volume":"23","author":"Kappelmann","year":"2018","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.jad.2026.121259_bb0130","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.bbi.2022.05.012","article-title":"Prospective associations of multimodal serum biomarkers with 12-week and 12-month remission in patients with depressive disorders receiving stepwise psychopharmacotherapy","volume":"104","author":"Kim","year":"2022","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.jad.2026.121259_bb0135","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jad.2020.05.002","article-title":"Short and long-term treatment outcomes of stepwise psychopharmacotherapy based on early clinical decision in patients with depressive disorders","volume":"274","author":"Kim","year":"2020","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2026.121259_bb0140","doi-asserted-by":"crossref","DOI":"10.1186\/s13148-021-01202-6","article-title":"Longitudinal DNA methylation dynamics as a practical indicator in clinical epigenetics","volume":"13","author":"Komaki","year":"2021","journal-title":"Clin. Epigenetics"},{"issue":"9","key":"10.1016\/j.jad.2026.121259_bb0145","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1177\/0269881117711708","article-title":"Anti-inflammatory treatment for major depressive disorder: implications for patients with an elevated immune profile and non-responders to standard antidepressant therapy","volume":"31","author":"Kopschina Feltes","year":"2017","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.jad.2026.121259_bb0150","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1186\/s13059-016-1119-5","article-title":"DNA methylation signatures of chronic low-grade inflammation are associated with complex diseases","volume":"17","author":"Ligthart","year":"2016","journal-title":"Genome Biol."},{"issue":"2","key":"10.1016\/j.jad.2026.121259_bb0155","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/s41380-019-0474-5","article-title":"Peripheral cytokine levels and response to antidepressant treatment in depression: a systematic review and meta-analysis","volume":"25","author":"Liu","year":"2020","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.jad.2026.121259_bb0160","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1126\/science.274.5288.740","article-title":"Evidence-based health policy\u2014lessons from the global burden of disease study","volume":"274","author":"Murray","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.jad.2026.121259_bb0165","series-title":"Depression in adults: treatment and management. NICE guideline","author":"National Institute for hHealth and cCare eExcellence (NICE)","year":"2022"},{"issue":"3","key":"10.1016\/j.jad.2026.121259_bb0170","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/mpr.256","article-title":"The Netherlands study of depression and anxiety (NESDA): rationale, objectives and methods","volume":"17","author":"Penninx","year":"2008","journal-title":"Int. J. Methods Psychiatr. Res."},{"key":"10.1016\/j.jad.2026.121259_bb0175","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.jad.2018.09.067","article-title":"A systematic meta-review of predictors of antidepressant treatment outcome in major depressive disorder","volume":"243","author":"Perlman","year":"2019","journal-title":"J. Affect. Disord."},{"issue":"1","key":"10.1016\/j.jad.2026.121259_bb0180","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1001\/2013.jamapsychiatry.4","article-title":"A randomized controlled trial of the tumor necrosis factor alpha antagonist infliximab in treatment-resistant depression: role of baseline inflammatory biomarkers","volume":"70","author":"Raison","year":"2013","journal-title":"JAMA Psychiatry"},{"issue":"11","key":"10.1016\/j.jad.2026.121259_bb0185","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1176\/ajp.2006.163.11.1905","article-title":"Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report","volume":"163","author":"Rush","year":"2006","journal-title":"Am. J. Psychiatry"},{"issue":"8","key":"10.1016\/j.jad.2026.121259_bb0190","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.3390\/ijms17081279","article-title":"Epigenetic modifications of major depressive disorder","volume":"17","author":"Saavedra","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jad.2026.121259_bb0195","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jpsychires.2016.02.023","article-title":"Exercise as a treatment for depression: a meta-analysis adjusting for publication bias","volume":"77","author":"Schuch","year":"2016","journal-title":"J. Psychiatr. Res."},{"issue":"Suppl. 20","key":"10.1016\/j.jad.2026.121259_bb0200","first-page":"22","article-title":"The Mini-international neuropsychiatric interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10","volume":"59","author":"Sheehan","year":"1998","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2026.121259_bb0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/NDT.S385117","article-title":"Anti-inflammatory treatment efficacy in major depressive disorder: a systematic review of meta-analyses","volume":"19","author":"Simon","year":"2023","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.jad.2026.121259_bb0210","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s13148-020-00903-8","article-title":"Characterisation of an inflammation-related epigenetic score and its association with cognitive ability","volume":"12","author":"Stevenson","year":"2020","journal-title":"Clin. Epigenetics"},{"issue":"1","key":"10.1016\/j.jad.2026.121259_bb0215","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s13148-020-00903-8","article-title":"Characterisation of an inflammation-related epigenetic score and its association with cognitive ability","volume":"12","author":"Stevenson","year":"2020","journal-title":"Clin. Epigenetics"},{"issue":"Suppl. 13","key":"10.1016\/j.jad.2026.121259_bb0220","first-page":"23","article-title":"When at first you don\u2019t succeed: sequential strategies for antidepressant nonresponders","volume":"58","author":"Thase","year":"1997","journal-title":"J. Clin. Psychiatry"},{"issue":"1\u20133","key":"10.1016\/j.jad.2026.121259_bb0225","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.schres.2013.10.011","article-title":"Antipsychotics\u2019 effects on blood levels of cytokines in schizophrenia: a systematic review and meta-analysis","volume":"151","author":"Tourjman","year":"2013","journal-title":"Schizophr. Res."},{"issue":"1","key":"10.1016\/j.jad.2026.121259_bb0230","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1176\/appi.ajp.163.1.28","article-title":"Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice","volume":"163","author":"Trivedi","year":"2006","journal-title":"Am. J. Psychiatry"},{"issue":"12","key":"10.1016\/j.jad.2026.121259_bb0235","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1038\/sj.npp.1301390","article-title":"Maximizing the adequacy of medication treatment in controlled trials and clinical practice: STAR*D measurement-based care","volume":"32","author":"Trivedi","year":"2007","journal-title":"Neuropsychopharmacology"},{"issue":"12","key":"10.1016\/j.jad.2026.121259_bb0240","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1176\/appi.ajp.2014.14010094","article-title":"An inflammatory biomarker as a differential predictor of outcome of depression treatment with escitalopram and nortriptyline","volume":"171","author":"Uher","year":"2014","journal-title":"Am. J. Psychiatry"},{"issue":"7","key":"10.1016\/j.jad.2026.121259_bb0245","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13863","article-title":"A DNA methylation based measure outperforms circulating CRP as a marker of chronic inflammation and partly reflects the monocytic response to long-term inflammatory exposure: a Canadian longitudinal study on aging analysis","volume":"22","author":"Verschoor","year":"2023","journal-title":"Aging Cell"},{"key":"10.1016\/j.jad.2026.121259_bb0250","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.pnpbp.2017.04.026","article-title":"Effect of antidepressant treatment on peripheral inflammation markers: a meta-analysis","volume":"80","author":"Wi\u0119d\u0142ocha","year":"2018","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.jad.2026.121259_bb0255","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-29792-6","article-title":"DNA methylation signature of chronic low-grade inflammation and its role in cardio-respiratory diseases","volume":"13","author":"Wielscher","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jad.2026.121259_bb0260","series-title":"Depressive disorder (depression)","author":"World Health Organization","year":"2023"},{"issue":"2","key":"10.1016\/j.jad.2026.121259_bb0265","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1177\/09622802241289559","article-title":"Is inverse probability of censoring weighting a safer choice than per-protocol analysis in clinical trials?","volume":"34","author":"Xuan","year":"2025","journal-title":"Stat. Methods Med. Res."},{"key":"10.1016\/j.jad.2026.121259_bb0270","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.jad.2019.07.045","article-title":"Inflammatory markers and treatment outcome in treatment resistant depression: a systematic review","volume":"257","author":"Yang","year":"2019","journal-title":"J. Affect. Disord."},{"issue":"1","key":"10.1016\/j.jad.2026.121259_bb0275","doi-asserted-by":"crossref","DOI":"10.1186\/s12888-025-06728-0","article-title":"Predicting the treatment outcomes of major depressive disorder interventions with baseline resting-state functional connectivity: a meta-analysis","volume":"25","author":"Zhou","year":"2025","journal-title":"BMC Psychiatry"},{"issue":"3","key":"10.1016\/j.jad.2026.121259_bb0280","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2025.1310","article-title":"Generalizability of treatment outcome prediction across antidepressant treatment trials in depression","volume":"8","author":"Zhukovsky","year":"2025","journal-title":"JAMA Netw. Open"}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032726001102?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032726001102?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T04:10:15Z","timestamp":1782274215000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032726001102"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":56,"alternative-id":["S0165032726001102"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2026.121259","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multimodal machine learning models for predicting remission in major depressive disorder using clinical data, blood biomarkers, and DNA methylation","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2026.121259","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"121259"}}